Loading insider details...
Latest Form 4 (Mar 7, 2026): Grant/Award of 900,000 LCTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 7, 2026 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 900,000 | n/a |
| Feb 14, 2026 | Lineage Cell Therapeutics, Inc. (LCTX) | Exercise/Conversion | 6,075 | n/a |
| Dec 20, 2025 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 1,735 | n/a |
| Mar 12, 2025 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 750,000 | n/a |
| Feb 12, 2025 | Lineage Cell Therapeutics, Inc. (LCTX) | Exercise/Conversion | 6,076 | n/a |
| Nov 26, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Purchase | 15,000 | $9.0K |
| Mar 8, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 650,000 | n/a |
| Feb 13, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Exercise/Conversion | 6,076 | n/a |
| Mar 11, 2023 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 650,000 | n/a |
| Feb 14, 2023 | Lineage Cell Therapeutics, Inc. (LCTX) | Exercise/Conversion | 6,076 | n/a |